This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 May;5(5):752-4.

doi: 10.1097/JTO.0b013e3181d6b8a1.

Safety of concomitant administration of seasonal and/or H1N1 flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancer

Gianluca Spitaleri, Angelo Delmonte, Francesca Toffalorio, Tommaso Martino De Pas, Vanesa Gregorc

PMID: 20421772
DOI: 10.1097/JTO.0b013e3181d6b8a1

Free article

Safety of concomitant administration of seasonal and/or H1N1 flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancer

Gianluca Spitaleri et al. J Thorac Oncol. 2010 May.

Free article

. 2010 May;5(5):752-4.

doi: 10.1097/JTO.0b013e3181d6b8a1.

Authors

Gianluca Spitaleri, Angelo Delmonte, Francesca Toffalorio, Tommaso Martino De Pas, Vanesa Gregorc

PMID: 20421772
DOI: 10.1097/JTO.0b013e3181d6b8a1

No abstract available

PubMed Disclaimer

Similar articles

Lung cancer response to gefitinib, then erlotinib, then gefitinib again.
Wong AS, Seto KY, Chin TM, Soo RA. Wong AS, et al. J Thorac Oncol. 2008 Sep;3(9):1077-8. doi: 10.1097/JTO.0b013e318183afb0. J Thorac Oncol. 2008. PMID: 18758318 No abstract available.
Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure.
Gridelli C, Maione P, Galetta D, Rossi A. Gridelli C, et al. J Thorac Oncol. 2007 Jan;2(1):96-8. doi: 10.1097/JTO.0b013e31802bffb0. J Thorac Oncol. 2007. PMID: 17410020 No abstract available.
Two generations of light/never-smokers with advanced adenocarcinoma of the lung with durable responses to erlotinib.
Pennell NA, Yin L, Keshtgarpour M, Ma PC. Pennell NA, et al. J Thorac Oncol. 2012 Jul;7(7):1200-1. doi: 10.1097/JTO.0b013e318250ed89. J Thorac Oncol. 2012. PMID: 22706608 No abstract available.
Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer.
Hotta K, Kiura K. Hotta K, et al. Expert Rev Anticancer Ther. 2011 Jul;11(7):991-7. doi: 10.1586/era.11.74. Expert Rev Anticancer Ther. 2011. PMID: 21806322 Review.
The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer.
Comis RL. Comis RL. Oncologist. 2005 Aug;10(7):467-70. doi: 10.1634/theoncologist.10-7-467. Oncologist. 2005. PMID: 16079313 Review. No abstract available.

See all similar articles

Cited by

Influenza vaccines in immunosuppressed adults with cancer.
Bitterman R, Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M. Bitterman R, et al. Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD008983. doi: 10.1002/14651858.CD008983.pub3. Cochrane Database Syst Rev. 2018. PMID: 29388675 Free PMC article.
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective.
Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, Orton E, Béchard-Evans L, Morgan G, Stevenson C, Weston R, Mukaigawara M, Enstone J, Augustine G, Butt M, Kim S, Puleston R, Dabke G, Howard R, O'Boyle J, O'Brien M, Ahyow L, Denness H, Farmer S, Figureroa J, Fisher P, Greaves F, Haroon M, Haroon S, Hird C, Isba R, Ishola DA, Kerac M, Parish V, Roberts J, Rosser J, Theaker S, Wallace D, Wigglesworth N, Lingard L, Vinogradova Y, Horiuchi H, Peñalver J, Nguyen-Van-Tam JS. Beck CR, et al. PLoS One. 2011;6(12):e29249. doi: 10.1371/journal.pone.0029249. Epub 2011 Dec 22. PLoS One. 2011. PMID: 22216224 Free PMC article.
Influenza vaccines in immunosuppressed adults with cancer.
Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M. Eliakim-Raz N, et al. Cochrane Database Syst Rev. 2013 Oct 29;2013(10):CD008983. doi: 10.1002/14651858.CD008983.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2018 Feb 01;2:CD008983. doi: 10.1002/14651858.CD008983.pub3. PMID: 24166741 Free PMC article. Updated.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information